1Siegler U, Kalberer C P, Nowbakht P,et al. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice [ J ]. Leukemia,2005,19(12) :2215-2222.
2Uberti J, Martilotti F, Chou T H, et al. Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells: implications for use of LAK cells to prevent graft-versus- host disease in allogeneic bone marrow transplantation [ J]. Blood, 1992,79( 1 ) :261-268.
3Torelli G F, Guarini A, Maggio I L, et al. Expansion of natural killer cells with lyric activity against autologous blasts from adult and pediatrie aeute lymphoid leukemia patients in eomplete hematologie remission[J]. Haematologica, 2005,90(6) :785-792.
4Guimaraes F, Guven H, Donati D, et al. Evaluation of in vivo expanded human NK cells on antileukemia activity in SCID-beige mice [J]. Leukemia, 2006, 20 (5): 833-839.
5Yoda Y, Abe T, Tashiro A ,et al. Normalized natural killer (NK) cell activity in long-term remission of acute leukemia [ J]. Br J Haematol, 1983,55(2) :305-309.
6Sentman C L, Barber M A, Barber A, et al. NK cell receptors as tools in cancer imnmnotherapy [J]. Adv Cancer Res, 2006,95 ( 1 ) :249-292.
7Koh C Y, Onaldo J R, Blazar B R, et al. NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade [ J ]. Blood, 2003,102 ( 12 ) :4067-4075.
